Curis (CRIS) Competitors

Curis (NASDAQ:CRIS) and Dominari (NASDAQ:DOMH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Do insiders and institutionals have more ownership in CRIS or DOMH?

30.0% of Curis shares are held by institutional investors. Comparatively, 42.5% of Dominari shares are held by institutional investors. 5.5% of Curis shares are held by company insiders. Comparatively, 33.0% of Dominari shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has more volatility and risk, CRIS or DOMH?

Curis has a beta of 3.66, suggesting that its share price is 266% more volatile than the S&P 500. Comparatively, Dominari has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500.

Is CRIS or DOMH more profitable?

Dominari has a net margin of -36.01% compared to Curis' net margin of -341.24%. Curis' return on equity of 0.00% beat Dominari's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Curis	-341.24%	N/A	-102.22%
Dominari	-36.01%	-94.32%	-78.21%

Does the media refer more to CRIS or DOMH?

In the previous week, Curis had 3 more articles in the media than Dominari. MarketBeat recorded 7 mentions for Curis and 4 mentions for Dominari. Curis' average media sentiment score of 0.90 beat Dominari's score of 0.16 indicating that Curis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Curis	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Dominari	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend CRIS or DOMH?

Curis presently has a consensus price target of $17.00, indicating a potential upside of 828.96%. Given Curis' stronger consensus rating and higher probable upside, equities research analysts clearly believe Curis is more favorable than Dominari.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Curis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dominari	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has stronger valuation & earnings, CRIS or DOMH?

Dominari has higher revenue and earnings than Curis. Dominari is trading at a lower price-to-earnings ratio than Curis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Curis	$10.91M	2.10	-$43.39M	-$4.88	-0.38
Dominari	$18.15M	5.42	-$14.70M	-$2.37	-2.70

Summary

Curis and Dominari tied by winning 8 of the 16 factors compared between the two stocks.